Quantitative Assay Development for PET
- 1 January 2004
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 160 references indexed in Scilit:
- Scaling down imaging: molecular mapping of cancer in miceNature Reviews Cancer, 2002
- Noninvasive, quantitative imaging in living animals of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transductionGene Therapy, 2001
- A Statistical Method for the Analysis of Positron Emission Tomography Neuroreceptor Ligand DataNeuroImage, 2000
- Synthesis of 9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): A potential imaging agent of viral infection and gene therapy using PETNuclear Medicine and Biology, 1996
- Biodistribution of iodine-125 tyramine transforming growth factor ? antisense oligonucleotide in athymic mice with a human mammary tumour xenograft following intratumoral injectionEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Circulatory Models of Intact-body Kinetics and their Relationship with Compartmental and Non-compartmental AnalysisJournal of Theoretical Biology, 1993
- Differentiation of Radioligand Delivery and Binding in the Brain: Validation of a Two-Compartment Model for [11C]FlumazenilJournal of Cerebral Blood Flow & Metabolism, 1991
- 3-N-(2-[18F]-fluoroethyl)-spiperone: A novel ligand for cerebral dopamine receptor studies with petLife Sciences, 1986
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985
- []-N-: The radioligand of choice for pett studies of the dopamine receptor in human brainLife Sciences, 1985